XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona Changes First Quarter Conference Call Date to May 10th

Dentsply Sirona Changes First Quarter Conference Call Date to May 10th

CHARLOTTE, N.C., May 02, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that its first quarter 2022 earnings conference call and live webcast will be held on Tuesday, May 10, 2022, at 8:30 am ET. The call had previously been scheduled for Thursday, May 5, 2022. A presentation related to the call will be available on the Investors section of the Company’s website at

Conference Call / Webcast Information 

The live webcast will be available on the Investors section of the Company’s website at For those planning to participate on the call, please dial  for domestic calls, or for international calls. A replay of the conference call will be available on the Investors section of the Company’s website at , and a dial-in replay will be available for one week following the call at  (for domestic calls) or (for international calls), replay conference ID # 6490428.

About Dentsply Sirona

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 135-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company, Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry. The Company’s shares of common stock are listed in the United States on Nasdaq under the symbol XRAY. Visit for more information about Dentsply Sirona and its products.

Contact Information

Investors:

Andrea Daley

VP, Investor Relations





EN
02/05/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DENTSPLY SIRONA Inc.

Dentsply Sirona Inc: 2 directors

Two Directors at Dentsply Sirona Inc bought/maiden bought 55,000 shares at between 13.469USD and 14.148USD. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company'...

 PRESS RELEASE

Dentsply Sirona to Participate in the Leerink Partners Global Healthca...

Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2026 CHARLOTTE, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Leerink Partners Global Healthcare Conference. Management is scheduled to present on Tuesday, March 10, 2026, at 10:00 a.m. EST. Investors and other interested parties will be able to access a live audio webcast and an audio webcast replay by visiting the Investors section of the Dentsply Sirona website at About Dentspl...

 PRESS RELEASE

Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Pro...

Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook News Summary Q4 2025 net sales of $961 million increased 6.2%, constant currency sales increased 2.5%Q4 2025 reported net loss of ($146) million and diluted loss per share of ($0.74) driven by goodwill and intangible impairments of ($144) million, net of taxQ4 2025 adjusted EPS of $0.27FY 2026 outlook: net sales in the range of $3.5B to $3.6B; adjusted EPS of $1.40 to $1.50(1)Announced a restructuring initiative to redirect approximately $120 million annually into the Return-to-Growth Action ...

 PRESS RELEASE

Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Dir...

Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors New directors bring decades of financial leadership and board experience to enhance strategic oversight of Return-to-Growth action plan and long-term value creation CHARLOTTE, N.C., Feb. 24, 2026 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced the appointments of James (Jim) D. Forbes and Brian P. McKeon to its Board of Directors (the “Board”), effective February 27, 2026. Mr. Forbes is a veteran healthcare investment banker with 30 years of experie...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch